Clinical proteomics

Keyphrases

Publications

volume 21, number 1, 2024

Chia-Li Han, Chi-Ting Lai, Aaron James Reyes, Hao-Chin Yang, Jin-Ying Lu, Shyang-Rong Shih, Kuen-Yuan Chen, Andrew N Hoofnagle, Sung-Liang Yu, William Bocik, Tara Hiltke, Huan-Chi Chiu, Ching-Yi Wan, Henry Rodriguez, Victoria Zhang, Yu-Ju Chen
Lessons learned: establishing a CLIA-equivalent laboratory for targeted mass spectrometry assays - navigating the transition from research to clinical practice. Clinical proteomics 21 (1) (2024)
Deborah Wenk, Charlotte Zuo, Thomas Kislinger, Lusia Sepiashvili
Recent developments in mass-spectrometry-based targeted proteomics of clinical cancer biomarkers. Clinical proteomics 21 (1) (2024)
Hui Wang, Xiaoyan Ni, Nicholas Clark, Kristen Randall, Lianne Boeglin, Sudha Chivukula, Caroline Woo, Frank DeRosa, Gang Sun
Absolute quantitation of human wild-type DNAI1 protein in lung tissue using a nanoLC-PRM-MS-based targeted proteomics approach coupled with immunoprecipitation. Clinical proteomics 21 (1) (2024)
Melanie A Govender, Stoyan H Stoychev, Jean-Tristan Brandenburg, Michèle Ramsay, June Fabian, Ireshyn S Govender
Proteomic insights into the pathophysiology of hypertension-associated albuminuria: Pilot study in a South African cohort. Clinical proteomics 21 (1) (2024)
Allison L Hunt, Nicholas W Bateman, Waleed Barakat, Sasha C Makohon-Moore, Tamara Abulez, Jordan A Driscoll, Joshua P Schaaf, Brian L Hood, Kelly A Conrads, Ming Zhou, Valerie Calvert, Mariaelena Pierobon, Jeremy Loffredo, Katlin N Wilson, Tracy J Litzi, Pang-Ning Teng, Julie Oliver, Dave Mitchell, Glenn Gist, Christine Rojas, Brian Blanton, Kathleen M Darcy, Uma N M Rao, Emanuel F Petricoin, Neil T Phippen, G Larry Maxwell, Thomas P Conrads
Mapping three-dimensional intratumor proteomic heterogeneity in uterine serous carcinoma by multiregion microsampling. Clinical proteomics 21 (1) (2024)
Neha Joshi, Kishore Garapati, Vivek Ghose, Richard K Kandasamy, Akhilesh Pandey
Recent progress in mass spectrometry-based urinary proteomics. Clinical proteomics 21 (1) (2024)
Sara R Savage, Yuefan Wang, Lijun Chen, Scott Jewell, Chelsea Newton, Yongchao Dou, Qing Kay Li, Oliver F Bathe, Ana I Robles, Gilbert S Omenn, Mathangi Thiagarajan, Hui Zhang, Galen Hostetter, Bing Zhang
Frozen tissue coring and layered histological analysis improves cell type-specific proteogenomic characterization of pancreatic adenocarcinoma. Clinical proteomics 21 (1) (2024)
Alexander B Saltzman, Doug W Chan, Matthew V Holt, Junkai Wang, Eric J Jaehnig, Meenakshi Anurag, Purba Singh, Anna Malovannaya, Beom-Jun Kim, Matthew J Ellis
Kinase inhibitor pulldown assay (KiP) for clinical proteomics. Clinical proteomics 21 (1) (2024)
Nina M Diederiks, L Renee Ruhaak, Fred P H T M Romijn, Mervin M Pieterse, Nico P M Smit, Christa M Cobbaert
An LC-MS-based designated comparison method with similar performance to the Lp(a) reference measurement procedure to guide molar Lp(a) standardization. Clinical proteomics 21 (1) (2024)
Allison L Hunt, Nicholas W Bateman, Waleed Barakat, Sasha C Makohon-Moore, Tamara Abulez, Jordan A Driscoll, Joshua P Schaaf, Brian L Hood, Kelly A Conrads, Ming Zhou, Valerie Calvert, Mariaelena Pierobon, Jeremy Loffredo, Katlin N Wilson, Tracy J Litzi, Pang-Ning Teng, Julie Oliver, Dave Mitchell, Glenn Gist, Christine Rojas, Brian Blanton, Kathleen M Darcy, Uma N M Rao, Emanuel F Petricoin, Neil T Phippen, G Larry Maxwell, Thomas P Conrads
Mapping three-dimensional intratumor proteomic heterogeneity in uterine serous carcinoma by multiregion microsampling. Clinical proteomics 21 (1) (2024)
Andreas Hentschel, Gina Piontek, Rob Dahlmann, Peter Findeisen, Roman Sakson, Phil Carbow, Thomas Renné, Yvonne Reinders, Albert Sickmann
Highly sensitive therapeutic drug monitoring of infliximab in serum by targeted mass spectrometry in comparison to ELISA data. Clinical proteomics 21 (1) (2024)
Yuqi Huang, Sheng Ma, Jun-Yu Xu, Kun Qian, Yaru Wang, Yi Zhang, Minjia Tan, Ting Xiao
Prognostic biomarker discovery based on proteome landscape of Chinese lung adenocarcinoma. Clinical proteomics 21 (1) (2024)
Yeonjin Jeon, GunHee Lee, Hwangkyo Jeong, Gyungyub Gong, JiSun Kim, Kyunggon Kim, Jae Ho Jeong, Hee Jin Lee
Proteomic analysis of breast cancer based on immune subtypes. Clinical proteomics 21 (1) (2024)
Tomonori Kaneko, Sally Ezra, Rober Abdo, Courtney Voss, Shanshan Zhong, Xuguang Liu, Owen Hovey, Marat Slessarev, Logan Robert Van Nynatten, Mingliang Ye, Douglas Fraser, Shawn Shun-Cheng Li
Kinome and phosphoproteome reprogramming underlies the aberrant immune responses in critically ill COVID-19 patients. Clinical proteomics 21 (1) (2024)
Melanie A Govender, Stoyan H Stoychev, Jean-Tristan Brandenburg, Michèle Ramsay, June Fabian, Ireshyn S Govender
Proteomic insights into the pathophysiology of hypertension-associated albuminuria: Pilot study in a South African cohort. Clinical proteomics 21 (1) (2024)
Sonu Das, Supriya Adiody, Jinsu Varghese, M Vanditha, Evelyn Maria, Mathew John
Exploring the novel duo of Reticulocalbin, and Sideroflexin as future biomarker candidates for Exacerbated Chronic Obstructive Pulmonary Disease. Clinical proteomics 21 (1) (2024)
Narae Kang, Hyun Jeong Oh, Ji Hye Hong, Hyo Eun Moon, Yona Kim, Hyeon-Jeong Lee, Hophil Min, Hyeonji Park, Sang Hun Lee, Sun Ha Paek, Jonghwa Jin
Correction: Glial cell proteome using targeted quantitative methods for potential multi-diagnostic biomarkers. Clinical proteomics 21 (1) (2024)
Hui Wang, Xiaoyan Ni, Nicholas Clark, Kristen Randall, Lianne Boeglin, Sudha Chivukula, Caroline Woo, Frank DeRosa, Gang Sun
Absolute quantitation of human wild-type DNAI1 protein in lung tissue using a nanoLC-PRM-MS-based targeted proteomics approach coupled with immunoprecipitation. Clinical proteomics 21 (1) (2024)
Tomonori Kaneko, Sally Ezra, Rober Abdo, Courtney Voss, Shanshan Zhong, Xuguang Liu, Owen Hovey, Marat Slessarev, Logan Robert Van Nynatten, Mingliang Ye, Douglas Fraser, Shawn Shun-Cheng Li
Kinome and phosphoproteome reprogramming underlies the aberrant immune responses in critically ill COVID-19 patients. Clinical proteomics 21 (1) (2024)
Nina M Diederiks, L Renee Ruhaak, Fred P H T M Romijn, Mervin M Pieterse, Nico P M Smit, Christa M Cobbaert
An LC-MS-based designated comparison method with similar performance to the Lp(a) reference measurement procedure to guide molar Lp(a) standardization. Clinical proteomics 21 (1) (2024)
Deborah Wenk, Charlotte Zuo, Thomas Kislinger, Lusia Sepiashvili
Recent developments in mass-spectrometry-based targeted proteomics of clinical cancer biomarkers. Clinical proteomics 21 (1) (2024)
Allison L Hunt, Nicholas W Bateman, Waleed Barakat, Sasha C Makohon-Moore, Tamara Abulez, Jordan A Driscoll, Joshua P Schaaf, Brian L Hood, Kelly A Conrads, Ming Zhou, Valerie Calvert, Mariaelena Pierobon, Jeremy Loffredo, Katlin N Wilson, Tracy J Litzi, Pang-Ning Teng, Julie Oliver, Dave Mitchell, Glenn Gist, Christine Rojas, Brian Blanton, Kathleen M Darcy, Uma N M Rao, Emanuel F Petricoin, Neil T Phippen, G Larry Maxwell, Thomas P Conrads
Mapping three-dimensional intratumor proteomic heterogeneity in uterine serous carcinoma by multiregion microsampling. Clinical proteomics 21 (1) (2024)
Sara R Savage, Yuefan Wang, Lijun Chen, Scott Jewell, Chelsea Newton, Yongchao Dou, Qing Kay Li, Oliver F Bathe, Ana I Robles, Gilbert S Omenn, Mathangi Thiagarajan, Hui Zhang, Galen Hostetter, Bing Zhang
Frozen tissue coring and layered histological analysis improves cell type-specific proteogenomic characterization of pancreatic adenocarcinoma. Clinical proteomics 21 (1) (2024)
Alexander B Saltzman, Doug W Chan, Matthew V Holt, Junkai Wang, Eric J Jaehnig, Meenakshi Anurag, Purba Singh, Anna Malovannaya, Beom-Jun Kim, Matthew J Ellis
Kinase inhibitor pulldown assay (KiP) for clinical proteomics. Clinical proteomics 21 (1) (2024)
Alexander B Saltzman, Doug W Chan, Matthew V Holt, Junkai Wang, Eric J Jaehnig, Meenakshi Anurag, Purba Singh, Anna Malovannaya, Beom-Jun Kim, Matthew J Ellis
Kinase inhibitor pulldown assay (KiP) for clinical proteomics. Clinical proteomics 21 (1) (2024)
Yeonjin Jeon, GunHee Lee, Hwangkyo Jeong, Gyungyub Gong, JiSun Kim, Kyunggon Kim, Jae Ho Jeong, Hee Jin Lee
Proteomic analysis of breast cancer based on immune subtypes. Clinical proteomics 21 (1) (2024)
Joohyun Ryu, Kristin L M Boylan, Carly A I Twigg, Richard Evans, Amy P N Skubitz, Stefani N Thomas
Quantification of putative ovarian cancer serum protein biomarkers using a multiplexed targeted mass spectrometry assay. Clinical proteomics 21 (1) (2024)
Esther Reijnders, Arnoud van der Laarse, L Renee Ruhaak, Christa M Cobbaert
Closing the gaps in patient management of dyslipidemia: stepping into cardiovascular precision diagnostics with apolipoprotein profiling. Clinical proteomics 21 (1) (2024)
Andreas Hentschel, Gina Piontek, Rob Dahlmann, Peter Findeisen, Roman Sakson, Phil Carbow, Thomas Renné, Yvonne Reinders, Albert Sickmann
Highly sensitive therapeutic drug monitoring of infliximab in serum by targeted mass spectrometry in comparison to ELISA data. Clinical proteomics 21 (1) (2024)
Jingyuan Hou, Qiaoting Deng, Xiaohong Qiu, Sudong Liu, Youqian Li, Changjing Huang, Xianfang Wang, Qunji Zhang, Xunwei Deng, Zhixiong Zhong, Wei Zhong
Proteomic analysis of plasma proteins from patients with cardiac rupture after acute myocardial infarction using TMT-based quantitative proteomics approach. Clinical proteomics 21 (1) (2024)
Chia-Li Han, Chi-Ting Lai, Aaron James Reyes, Hao-Chin Yang, Jin-Ying Lu, Shyang-Rong Shih, Kuen-Yuan Chen, Andrew N Hoofnagle, Sung-Liang Yu, William Bocik, Tara Hiltke, Huan-Chi Chiu, Ching-Yi Wan, Henry Rodriguez, Victoria Zhang, Yu-Ju Chen
Lessons learned: establishing a CLIA-equivalent laboratory for targeted mass spectrometry assays - navigating the transition from research to clinical practice. Clinical proteomics 21 (1) (2024)
Neha Joshi, Kishore Garapati, Vivek Ghose, Richard K Kandasamy, Akhilesh Pandey
Recent progress in mass spectrometry-based urinary proteomics. Clinical proteomics 21 (1) (2024)
Neha Joshi, Kishore Garapati, Vivek Ghose, Richard K Kandasamy, Akhilesh Pandey
Recent progress in mass spectrometry-based urinary proteomics. Clinical proteomics 21 (1) (2024)
Andreas Hentschel, Gina Piontek, Rob Dahlmann, Peter Findeisen, Roman Sakson, Phil Carbow, Thomas Renné, Yvonne Reinders, Albert Sickmann
Highly sensitive therapeutic drug monitoring of infliximab in serum by targeted mass spectrometry in comparison to ELISA data. Clinical proteomics 21 (1) (2024)
Sonu Das, Supriya Adiody, Jinsu Varghese, M Vanditha, Evelyn Maria, Mathew John
Exploring the novel duo of Reticulocalbin, and Sideroflexin as future biomarker candidates for Exacerbated Chronic Obstructive Pulmonary Disease. Clinical proteomics 21 (1) (2024)
Petri Mäkinen, Janika Nättinen, Ulla Aapola, Juhani Pietilä, Hannu Uusitalo
Comparison of early changes in tear film protein profiles after small incision lenticule extraction (SMILE) and femtosecond LASIK (FS-LASIK) surgery. Clinical proteomics 21 (1) (2024)
Narae Kang, Hyun Jeong Oh, Ji Hye Hong, Hyo Eun Moon, Yona Kim, Hyeon-Jeong Lee, Hophil Min, Hyeonji Park, Sang Hun Lee, Sun Ha Paek, Jonghwa Jin
Correction: Glial cell proteome using targeted quantitative methods for potential multi-diagnostic biomarkers. Clinical proteomics 21 (1) (2024)
Petri Mäkinen, Janika Nättinen, Ulla Aapola, Juhani Pietilä, Hannu Uusitalo
Comparison of early changes in tear film protein profiles after small incision lenticule extraction (SMILE) and femtosecond LASIK (FS-LASIK) surgery. Clinical proteomics 21 (1) (2024)
Hui Wang, Xiaoyan Ni, Nicholas Clark, Kristen Randall, Lianne Boeglin, Sudha Chivukula, Caroline Woo, Frank DeRosa, Gang Sun
Absolute quantitation of human wild-type DNAI1 protein in lung tissue using a nanoLC-PRM-MS-based targeted proteomics approach coupled with immunoprecipitation. Clinical proteomics 21 (1) (2024)
Joohyun Ryu, Kristin L M Boylan, Carly A I Twigg, Richard Evans, Amy P N Skubitz, Stefani N Thomas
Quantification of putative ovarian cancer serum protein biomarkers using a multiplexed targeted mass spectrometry assay. Clinical proteomics 21 (1) (2024)
Sara R Savage, Yuefan Wang, Lijun Chen, Scott Jewell, Chelsea Newton, Yongchao Dou, Qing Kay Li, Oliver F Bathe, Ana I Robles, Gilbert S Omenn, Mathangi Thiagarajan, Hui Zhang, Galen Hostetter, Bing Zhang
Frozen tissue coring and layered histological analysis improves cell type-specific proteogenomic characterization of pancreatic adenocarcinoma. Clinical proteomics 21 (1) (2024)
Yeonjin Jeon, GunHee Lee, Hwangkyo Jeong, Gyungyub Gong, JiSun Kim, Kyunggon Kim, Jae Ho Jeong, Hee Jin Lee
Proteomic analysis of breast cancer based on immune subtypes. Clinical proteomics 21 (1) (2024)
Nina M Diederiks, L Renee Ruhaak, Fred P H T M Romijn, Mervin M Pieterse, Nico P M Smit, Christa M Cobbaert
An LC-MS-based designated comparison method with similar performance to the Lp(a) reference measurement procedure to guide molar Lp(a) standardization. Clinical proteomics 21 (1) (2024)
Deborah Wenk, Charlotte Zuo, Thomas Kislinger, Lusia Sepiashvili
Recent developments in mass-spectrometry-based targeted proteomics of clinical cancer biomarkers. Clinical proteomics 21 (1) (2024)
Jingyuan Hou, Qiaoting Deng, Xiaohong Qiu, Sudong Liu, Youqian Li, Changjing Huang, Xianfang Wang, Qunji Zhang, Xunwei Deng, Zhixiong Zhong, Wei Zhong
Proteomic analysis of plasma proteins from patients with cardiac rupture after acute myocardial infarction using TMT-based quantitative proteomics approach. Clinical proteomics 21 (1) (2024)
Esther Reijnders, Arnoud van der Laarse, L Renee Ruhaak, Christa M Cobbaert
Closing the gaps in patient management of dyslipidemia: stepping into cardiovascular precision diagnostics with apolipoprotein profiling. Clinical proteomics 21 (1) (2024)
Alexander B Saltzman, Doug W Chan, Matthew V Holt, Junkai Wang, Eric J Jaehnig, Meenakshi Anurag, Purba Singh, Anna Malovannaya, Beom-Jun Kim, Matthew J Ellis
Kinase inhibitor pulldown assay (KiP) for clinical proteomics. Clinical proteomics 21 (1) (2024)
Alexander B Saltzman, Doug W Chan, Matthew V Holt, Junkai Wang, Eric J Jaehnig, Meenakshi Anurag, Purba Singh, Anna Malovannaya, Beom-Jun Kim, Matthew J Ellis
Kinase inhibitor pulldown assay (KiP) for clinical proteomics. Clinical proteomics 21 (1) (2024)
Yuqi Huang, Sheng Ma, Jun-Yu Xu, Kun Qian, Yaru Wang, Yi Zhang, Minjia Tan, Ting Xiao
Prognostic biomarker discovery based on proteome landscape of Chinese lung adenocarcinoma. Clinical proteomics 21 (1) (2024)
Joohyun Ryu, Kristin L M Boylan, Carly A I Twigg, Richard Evans, Amy P N Skubitz, Stefani N Thomas
Quantification of putative ovarian cancer serum protein biomarkers using a multiplexed targeted mass spectrometry assay. Clinical proteomics 21 (1) (2024)